Fusion Fuel Secures 100 kW Electrolyzer Contract for Hospital in Iberia
Rhea-AI Summary
Fusion Fuel (NASDAQ: HTOO) announced a 100 kW electrolyzer supply contract for a hospital in Iberia, aiming to generate green hydrogen for emissions-free power and capture green oxygen for medical use.
The project includes R&D efforts to develop and test new materials for their HEVO micro-electrolyzer technology, potentially leading to additional revenue from technology and equipment supply.
This initiative marks Fusion Fuel's entry into the healthcare sector and underscores its commitment to innovative clean energy solutions.
Positive
- Signed a 100 kW electrolyzer supply contract, marking entry into the healthcare sector.
- Hospital client intends to use green hydrogen for emissions-free power and green oxygen for medical applications.
- R&D workstream included in the project for developing new materials, potentially leading to additional revenue.
- Second project using the oxygen capture system, previously piloted with a cement client.
Negative
- No financial details about the contract were disclosed.
- Potential technical challenges and risks associated with the R&D workstream and new material development.
News Market Reaction – HTOO
In the trading session that priced this news, HTOO declined 4.92%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SABUGO, Portugal, June 05, 2024 (GLOBE NEWSWIRE) -- Fusion Fuel (NASDAQ: HTOO) announced today that it has signed a 100 kW electrolyzer supply contract for a hospital client in Iberia. The hospital intends to capture the green oxygen created as a byproduct of the electrolysis process for medical applications and to use the green hydrogen generated to produce emissions-free power for the facility. The project also includes an R&D workstream aimed at developing and testing new materials for the Gas Diffusion Layer and Porous Transport Layer within Fusion Fuel’s HEVO micro-electrolyzer technology. The company expects the R&D engagement to contribute additional technology and equipment supply revenue beyond the initial 100 kW system. The project reflects Fusion Fuel’s commitment to developing and delivering innovative solutions that help our customers realize their clean energy goals.
Frederico Figueira de Chaves, Fusion Fuel’s CEO, commented, “We are delighted to announce the signing of this contract, which also marks our initial inroads into a new industry segment as the end-user is a hospital in Iberia. It's also interesting to note that the primary driver of this opportunity is to secure the supply of medical-grade green oxygen for use at the facility. We are thrilled to add a second project utilizing our oxygen capture system, first piloted at our project for a cement client earlier this year. This technology provides a unique way for industrial and medical customers to produce efficient and environmentally friendly green hydrogen, while also creating a cost-effective way to capture high-purity green oxygen.”
About Fusion Fuel Green plc
Fusion Fuel is an emerging leader in the green hydrogen sector committed to accelerating the energy transition through the development of disruptive, clean hydrogen solutions. Fusion Fuel’s patented miniaturized Proton Exchange Membrane (PEM) electrolyzer – the HEVO – and building-block approach to green hydrogen production, unlock unprecedented modularity, flexibility, and reliability in the design and deployment of small-to-midscale green hydrogen solutions. Its business lines include the sale of its electrolyzer systems, the development and sale of turnkey hydrogen plants, and the provision of end-to-end project engineering and advisory services. Learn more about Fusion Fuel by visiting our website at https://www.fusion-fuel.eu, and by following us on LinkedIn.
Fusion Fuel Investor Relations Contact
ir@fusion-fuel.eu
